Skip to main content
OpenTrials

Clinical trial condition

Extensively Drug-Resistant Tuberculosis

Explore clinical trials studying Extensively Drug-Resistant Tuberculosis. Study availability and eligibility vary by location and protocol.

21 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Extensively Drug-Resistant Tuberculosis trial results

Completed

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

NCT03086486

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +13 more
Locations
  • National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • Institute of Phthisiopneumology Chiril Draganiuc Chisinau, Moldova
  • Moscow City Research and Practice Tuberculosis Treatment Centre Moscow, Russia
  • Central TB Research Institute of the Federal Agency of Scientific Organizations Moscow Moscow, Russia
View Trial Details
Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

NCT00685360

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations
  • University of Texas Health Center at Tyler / Heartland National TB Center / Texas Center for Infectious Disease San Antonio, Texas, United States
  • Beijing Chest Hospital Beijing, China
  • Shanghai Pulmonary Hospital Shanghai, China
  • Abbassia Chest Hospital Cairo, Egypt
View all 17 locations
View Trial Details
Completed

Tuberculosis in China

NCT01071603

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • Henan Provincial Chest Hospital Zhengzhou, China
View Trial Details
Completed

Global Consortium for Drug-resistant Tuberculosis Diagnostics

NCT02170441

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • P.D. Hinduja National Hospital and Medical Research Centre Mumbai, India
  • Phthisiopneumology Institute Chisinau, Moldova
  • Department of Biomedical Sciences, Stellenbosch University Cape Town, South Africa
View Trial Details

Related conditions